AI

biotech

Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease

Jim Cornall - October 9, 2026

biotech

Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts

Jim Cornall - October 8, 2026

biotech

Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China

Jim Cornall - October 8, 2026

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026

AI

Ryght AI and Biorasi to partner on AI

Jim Cornall - August 21, 2025

AI

Novel gene therapy for ALS cleared for trials in US and China

Jim Cornall - August 19, 2025

AI

Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins

Jim Cornall - August 19, 2025

AI

KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations

admin - August 11, 2025

AI

Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA

Jim Cornall - August 8, 2025

AI

Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance

Jim Cornall - July 18, 2025

AI

Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity

Jim Cornall - July 4, 2025

AI

I-Corps Hub West accelerates deeptech commercialisation in western US

Jim Cornall - June 17, 2025

123...7 Page 2 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease

Jim Cornall - October 9, 2026 0

This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have...

Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts

biotech Jim Cornall - October 8, 2026 0

Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China

biotech Jim Cornall - October 8, 2026 0

How cells fight back after bacterial toxins break through

biotech Jim Cornall - October 8, 2026 0

New approach to treating chronic wounds

biotech Jim Cornall - October 7, 2026 0